Martinrea downgraded to Market Perform from Outperform at BMO Capital

BMO Capital analyst Tamy Chen downgraded Martinrea (MRETF) to Market Perform from Outperform with a price target of C$11, down from C$13. The firm expects flat industry production in North America in 2025 and says Martinrea’s performance will largely trend with industry production.